Talcum Powder Cancer Lawsuit News

Third Talcum Powder Ovarian Cancer Lawsuit Ends in $70 Million Verdict Against Johnson & Johnson - October 27, 2016


Bookmark and Share


British Study Cited in Talcum Powder Cancer Lawsuit News

Much of the evidence in cases involved in recent talcum powder ovarian cancer lawsuit news was influenced by a British talc study that was published more than four decades ago.

Friday, February 12, 2016 - In recent talcum powder lawsuit news, there are currently hundreds of talcum lawsuits pending around the country alleging a link between regular talcum powder use by women and a heightened risk of contracting ovarian cancer. Much of the research supporting evidence behind plaintiffs’ claims began with a single study conducted in 1971. The initial study looking at the link between talcum powder and ovarian cancer has served as a jumping off point for more than 20 similar studies that have examined the potential cancerous aspects of talcum powder use. These studies have emboldened the plaintiffs to allege that Johnson & Johnson had the materials and awareness available to identify the potential dangers of their talcum powder products but decided against warning consumers of the connection.

The initial study, published 45 years ago, first appeared in the British Journal of Obstetrics and Gynaecology and has been referenced repeatedly as the first serious look into possible connections between talcum powder and ovarian cancer. Authored by W.J. Henderson, the study looked into a collection of tumors that had been removed from patients who had ovarian cancer. 13 tumors were examined over the duration of the study, with 10 of them revealing talc particles within the samples. Though a small sample size, the result was sufficient for the study to conclude that the findings were significant enough to claim a correlation between talcum powder and ovarian cancer.

The research also noted the close relationship between asbestos and talc, which are commonly mined together. The Food and Drug Administration did not ban the presence of asbestos in U.S. talc products until 1973, two years after the study was published. Though this may have affected the results, talcum powder research that has taken place since the British study have continued to find similar results connecting talcum powder and ovarian cancer. As more studies have been published claiming positive correlations between the substance and cancer, talcum powder cancer lawsuit news has grown throughout the U.S. and catalyzed the filing of related lawsuits.

Though many talcum research studies have found consistent data purporting a link between talcum powder and an increased risk in ovarian cancer, a number of leading agencies have yet to take a firm stance on the issue. Both the FDA and the International Agency for Research on Cancer have yet to make impactful statements related to talcum powder ovarian cancer lawsuit news, though both mention talc and determine that though a connection between the substance and ovarian cancer has been investigated there has been no conclusive studies to the point that either would independently confirm a link between the two. Johnson & Johnson, the main defendant in the lawsuits, has also turned out a number of studies that failed to discern any link between talcum powder and ovarian cancer.

Still, there have been a number of studies conducted from sources such as Harvard, Boston University and the medical journal Cancer Prevention Research that have discovered significant links between talcum powder and ovarian cancer. These studies follow in the footsteps of the first British study in declaring a significant increase in the risk of ovarian cancer as a result of the regular, genital use of talcum powder by women. Additional studies have even discovered the percentage increased rise as rising up to 35 percent as a result of a women’s regular use talcum powder.

Given the number of lawsuits currently pending around the country and the preponderance of talcum powder ovarian cancer lawsuit news stories, it is likely that talcum powder research is ongoing and will continue to bolster the research that has already been published.

No-Cost, No-Obligation Baby Powder Cancer Lawsuit Case Review for Women and Families of Women Who Were Diagnosed with Ovarian Cancer and Have a History of Using Talcum Powder

The Onder Law Firm

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others, and other law firms throughout the nation often seek its experience and expertise on complex litigation. For more information, visit Talcum Powder Cancer Lawsuit Center or call 1-877-ONDER-LAW.


Talcum Powder and Ovarian Cancer

As early as the 1970s, ovarian cancer experts have linked the routine use of baby powder for genital hygiene to an increased risk for contracting ovarian cancer. Putting any product that contains talc, including feminine body powders and talcum baby powders, on the genital area yields a 33% higher risk of cancer.

Learn more »

Baby Powder Ovarian Cancer Warnings

A wide variety of groups, ranging from cancer prevention organizations to states' health departments and even cosmetic industry representatives, have acknowledged the baby powder cancer link. Read the warnings links to numerous baby powder ovarian cancer warning statements.

Learn more »

Talcum Powder Ovarian Cancer Lawsuits

If you or a loved one has suffered from ovarian cancer and have a history of using talcum powder, you may be eligible to participate in a Talcum Powder Ovarian Cancer Lawsuit.  Talcum Powder Ovarian Cancer Lawsuits, which are NOT class action lawsuits, may ultimately prevent other women from suffering this tragedy.

Learn more »


Onder Law handles cases nationwide including Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin and Wyoming.

Onder Law represents clients in Atlanta, GA, Austin, TX, Baltimore, MD, Birmingham, AL, Boston, MA, Buffalo, NY, Charlotte, NC, Chicago, IL, Cincinnati, OH, Cleveland, OH, Columbus, OH, Dallas, TX, Denver, CO, Detroit, MI, Fresno, CA, Hartford, CT, Honolulu, HI, Houston, TX, Indianapolis, IN, acksonville, FL, Kansas City, MO, Las Vegas, NV, Los Angeles, CA, Louisville, KY, Memphis, TN, Miami, FL, Milwaukee, WI, Minneapolis, MN, Nashville, TN, New Orleans, LA, New York, NY, Oklahoma City, OK, Orlando, FL, Philadelphia, PA, Phoenix, AZ, Pittsburgh, PA, Portland, OR, Providence, RI, Raleigh, NC, Richmond, VA, Riverside, CA, Rochester, NY, Sacramento, CA, Salt Lake City, UT, San Antonio, TX, San Diego, CA San Francisco, CA, San Jose, CA, Seattle, WA, St. Louis, MO, Tampa, FL, Tucson, AZ, Tulsa, OK, Virginia Beach, VA and Washington, DC.